Pierre Demolis

Affiliations

Agence Nationale de Sécurité du Médicament et des Produits de Santé and European Medicines Agency, Scientific Advice Working Party and Oncology Working Party, Amsterdam, the Netherlands.

Réseau de co-auteurs

Giovanni Lesa 3 collaborations

Franca Ligas 3 collaborations

Andrew D J Pearson 2 collaborations

Susan Weiner 2 collaborations

Veronique Minard-Colin 2 collaborations

Lynley V Marshall 2 collaborations

Hubert Caron 2 collaborations

Sara Galluzzo 2 collaborations

Dominik Karres 2 collaborations

Jaroslav Sterba 2 collaborations

Koenraad Norga 2 collaborations

Gregory Reaman 2 collaborations

Gilles Vassal 2 collaborations

Claudia Rossig 1 collaboration

Scott J Diede 1 collaboration

John Anderson 1 collaboration

Juliet Gray 1 collaboration

Birgit Geoerger 1 collaboration

Malcolm Smith 1 collaboration

Paul Sondel 1 collaboration

Marcis Bajars 1 collaboration

Claudia Baldazzi 1 collaboration

Elly Barry 1 collaboration

Sam Blackman 1 collaboration

Patricia Blanc 1 collaboration

Renaud Capdeville 1 collaboration

Peter D Cole 1 collaboration

Jorge Camarero Jiménez 1 collaboration

Martha Donoghue 1 collaboration

Mabrouck Elgadi 1 collaboration

Thomas Gajewski 1 collaboration

Robert Ilaria 1 collaboration

Alessandro Jenkner 1 collaboration

Mark Kieran 1 collaboration

Israel Lowy 1 collaboration

Michael Meyers 1 collaboration

Corina Oprea 1 collaboration

Vijay G R Peddareddigari 1 collaboration

Paul K Stockman 1 collaboration

Peter Suenaert 1 collaboration

Uri Tabori 1 collaboration

Cornelis van Tilburg 1 collaboration

Todd Yancey 1 collaboration

Brenda Weigel 1 collaboration

Pia Annunen 1 collaboration

Maaike van Dartel 1 collaboration

Ralf Herold 1 collaboration

Olga Kholmanskikh van Criekingen 1 collaboration

Violeta Stoyanova-Beninska 1 collaboration

Koen Norga 1 collaboration

Nicole Scobie 1 collaboration

Davy Chiodin 1 collaboration

Amos Burke 1 collaboration

Peter Adamson 1 collaboration

Arun Balakumaran 1 collaboration

Bouchra Benettaib 1 collaboration

Pankaj Bhargava 1 collaboration

Catherine M Bollard 1 collaboration

Ellen Bolotin 1 collaboration

Simon Bomken 1 collaboration

Jochen Buechner 1 collaboration

Birgit Burkhardt 1 collaboration

Christopher Copland 1 collaboration

Anton Egorov 1 collaboration

Mahdi Farhan 1 collaboration

Gerhard Zugmaier 1 collaboration

Thomas Gross 1 collaboration

Danielle Horton-Taylor 1 collaboration

Wolfram Klapper 1 collaboration

Robert Marcus 1 collaboration

Rodney R Miles 1 collaboration

Kerri Nottage 1 collaboration

Lida Pacaud 1 collaboration

Rosanna Ricafort 1 collaboration

Martin Schrappe 1 collaboration

Remus Vezan 1 collaboration

Su Young Kim 1 collaboration

Sarah A Holstein 1 collaboration

Nizar Bahlis 1 collaboration

P Leif Bergsagel 1 collaboration

Manisha Bhutani 1 collaboration

Niccolo Bolli 1 collaboration

Carrie Brownstein 1 collaboration

David Foureau 1 collaboration

Francesca Gay 1 collaboration

Irene M Ghobrial 1 collaboration

Nicole Gormley 1 collaboration

Jens Hillengass 1 collaboration

Martin Kaiser 1 collaboration

Marcela V Maus 1 collaboration

J Joseph Melenhorst 1 collaboration

Maximilian Merz 1 collaboration

Michael O Dwyer 1 collaboration

Bruno Paiva 1 collaboration

Marcelo C Pasquini 1 collaboration

Nina Shah 1 collaboration

Sandy W Wong 1 collaboration

Saad Z Usmani 1 collaboration

Philip L McCarthy 1 collaboration

Pierre Demolis

Affiliations

Publications (4)

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.

Can a Multistakeholder Prioritization Structure Support Regulatory Decision Making? A Review of Pediatric Oncology Strategy Forums Reflecting on Challenges and Opportunities of this Concept.

ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.

The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma.

Réseau de co-auteurs